Compare GSK Consumer with VENKYS (I) LIMITED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VENKYS (I) LIMITED - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VENKYS (I) LIMITED GSK CONSUMER/
VENKYS (I) LIMITED
 
P/E (TTM) x 39.1 16.5 236.8% View Chart
P/BV x 11.0 1.9 592.2% View Chart
Dividend Yield % 1.0 0.7 142.3%  

Financials

 GSK CONSUMER   VENKYS (I) LIMITED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
VENKYS (I) LIMITED
Mar-19
GSK CONSUMER/
VENKYS (I) LIMITED
5-Yr Chart
Click to enlarge
High Rs7,8194,725 165.5%   
Low Rs5,8321,787 326.4%   
Sales per share (Unadj.) Rs1,136.92,159.8 52.6%  
Earnings per share (Unadj.) Rs233.7123.6 189.1%  
Cash flow per share (Unadj.) Rs248.1144.4 171.8%  
Dividends per share (Unadj.) Rs105.008.00 1,312.5%  
Dividend yield (eoy) %1.50.2 626.1%  
Book value per share (Unadj.) Rs973.5625.6 155.6%  
Shares outstanding (eoy) m42.0614.09 298.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.01.5 398.2%   
Avg P/E ratio x29.226.3 110.9%  
P/CF ratio (eoy) x27.522.5 122.1%  
Price / Book Value ratio x7.05.2 134.7%  
Dividend payout %44.96.5 694.2%   
Avg Mkt Cap Rs m287,08345,874 625.8%   
No. of employees `0003.85.5 69.7%   
Total wages/salary Rs m6,4461,945 331.4%   
Avg. sales/employee Rs Th12,440.25,520.9 225.3%   
Avg. wages/employee Rs Th1,677.0352.8 475.3%   
Avg. net profit/employee Rs Th2,556.7315.9 809.3%   
INCOME DATA
Net Sales Rs m47,82030,431 157.1%  
Other income Rs m4,326290 1,491.2%   
Total revenues Rs m52,14630,721 169.7%   
Gross profit Rs m11,4103,084 370.0%  
Depreciation Rs m606294 206.3%   
Interest Rs m8316 2.5%   
Profit before tax Rs m15,1232,765 546.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,2951,024 517.2%   
Profit after tax Rs m9,8281,741 564.4%  
Gross profit margin %23.910.1 235.4%  
Effective tax rate %35.037.0 94.6%   
Net profit margin %20.65.7 359.2%  
BALANCE SHEET DATA
Current assets Rs m52,6748,904 591.6%   
Current liabilities Rs m18,1405,877 308.7%   
Net working cap to sales %72.29.9 726.1%  
Current ratio x2.91.5 191.7%  
Inventory Days Days3625 141.8%  
Debtors Days Days2937 80.3%  
Net fixed assets Rs m4,7985,675 84.6%   
Share capital Rs m421141 298.5%   
"Free" reserves Rs m40,5278,674 467.2%   
Net worth Rs m40,9478,815 464.5%   
Long term debt Rs m0399 0.0%   
Total assets Rs m60,68115,573 389.6%  
Interest coverage x1,939.89.8 19,866.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.82.0 40.3%   
Return on assets %16.213.2 122.7%  
Return on equity %24.019.8 121.5%  
Return on capital %37.033.4 110.5%  
Exports to sales %00.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA200 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171200 1,583.9%   
Fx outflow Rs m1,770725 244.1%   
Net fx Rs m1,401-525 -266.9%   
CASH FLOW
From Operations Rs m6,7111,589 422.3%  
From Investments Rs m-3,351-383 875.5%  
From Financial Activity Rs m-3,768-1,204 312.9%  
Net Cashflow Rs m-4082 -19,419.0%  

Share Holding

Indian Promoters % 0.0 56.1 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 8.8 9.1%  
FIIs % 12.0 3.2 381.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 31.9 46.4%  
Shareholders   26,457 20,089 131.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   RADICO KHAITAN  TATA COFFEE  GOODRICKE  ADVANTA LTD.  REI AGRO LTD.  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Related Views on News

VENKYS (I) LIMITED Announces Quarterly Results (3QFY20); Net Profit Down 108.7% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, VENKYS (I) LIMITED has posted a net profit of Rs 59 m (down 108.7% YoY). Sales on the other hand came in at Rs 9 bn (up 8.4% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VENKYS (I) LIMITED 2018-19 Annual Report Analysis (Annual Result Update)

Sep 16, 2019 | Updated on Sep 16, 2019

Here's an analysis of the annual report of VENKYS (I) LIMITED for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of VENKYS (I) LIMITED. Also includes updates on the valuation of VENKYS (I) LIMITED.

VENKYS (I) LIMITED Announces Quarterly Results (1QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Aug 7, 2019 | Updated on Aug 7, 2019

For the quarter ended June 2019, VENKYS (I) LIMITED has posted a net profit of Rs 618 m (down 13.0% YoY). Sales on the other hand came in at Rs 9 bn (up 19.7% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS